SCHEMBL1099258

SCHEMBL1099258

O=S(=O)(c1ccccc1)N(CCN1CCCCC1)c1sc2ccccc2c1Br

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 2/20 0.45
ALDH1A1 P00352 2/20 0.41
KMT2A Q03164 2/20 0.40
CYP1A2 P05177 1/20 0.38
CYP2D6 P10635 1/20 0.38
CYP2C9 P11712 1/20 0.38
HSD17B10 Q99714 1/20 0.38
HTR7 P34969 3/20 0.37
HTR1A P08908 2/20 0.37
DRD2 P14416 2/20 0.37
HTR2A P28223 2/20 0.37
HTR6 P50406 2/20 0.37
HRH3 Q9Y5N1 1/20 0.37
GAA P10253 1/20 0.36
ESR1 P03372 2/20 0.36
ESR2 Q92731 2/20 0.36
CHRNA7 P36544 1/20 0.36
CXCR4 P61073 1/20 0.35
MMP3 P08254 1/20 0.35
CRHBP P24387 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1098240 0.89 MEN1 (0.44) ALDH1A1KMT2AHTR7HTR1ADRD2
SCHEMBL1099920 0.87 TRPM8 (0.44) SIGMAR1ALDH1A1KMT2ACYP1A2CYP2D6
SCHEMBL1099099 0.83 ADAMTS5 (0.42) ALDH1A1KMT2ASMN1; SMN2
SCHEMBL1099720 0.83 ADAMTS5 (0.35) ALDH1A1KMT2AHTR7HTR1ADRD2
SCHEMBL1098592 0.81 TRPM8 (0.49) ALDH1A1GAAMMP3SMN1; SMN2
SCHEMBL1099478 0.81 RET (0.40) ALDH1A1KMT2ACYP1A2CYP2D6CYP2C9
SCHEMBL1098844 0.79 NR1I2 (0.44) ALDH1A1KMT2AESR1SMN1; SMN2
SCHEMBL1097407 0.79 KEAP1 (0.37) HTR7HTR1ADRD2HTR2AHTR6
SCHEMBL1099694 0.79 KDM4E (0.37) ALDH1A1KMT2AHTR2A
SCHEMBL1099577 0.78 RORC (0.48) ALDH1A1ESR1ESR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9434711-B2 Sulfonamides as TRPM8 modulators JANSSEN PHARMACEUTICA, N.V. (BE) 2016-09-06 US disclosed
US-20140315899-A1 SULFONAMIDES AS TRPM8 MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2014-10-23 US disclosed
US-8809327-B2 Sulfonamides as TRPM8 modulators JANSSEN PHARMACEUTICA, NV (BE) 2014-08-19 US disclosed
EP-2183239-B1 SULFONAMIDES AS TRPM8 MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2012-08-22 EP disclosed
US-20120190674-A1 SULFONAMIDES AS TRPM8 MODULATORS BRANUM SHAWN T (US) 2012-07-26 US disclosed
US-8153682-B2 Sulfonamides as TRPM8 modulators JANSSEN PHARMACEUTICA, NV (BE) 2012-04-10 US disclosed
US-20090264474-A1 SULFONAMIDES AS TRPM8 MODULATORS JANSSEN PHARMACEUTICA, N.V. (BE) 2009-10-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120190674-A1 SULFONAMIDES AS TRPM8 MODULATORS TRPM8, TRPM5, TRPM2 SIGMAR1 377/4885ALDH1A1 3091/4885KMT2A 1231/4885
US-20140315899-A1 SULFONAMIDES AS TRPM8 MODULATORS TRPM8, TRPM5, TRPM2 SIGMAR1 377/4885ALDH1A1 3091/4885KMT2A 1231/4885
US-20090264474-A1 SULFONAMIDES AS TRPM8 MODULATORS TRPM8, TRPM5, TRPM2 SIGMAR1 377/4885ALDH1A1 3091/4885KMT2A 1231/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.